Last $19.00 USD
Change Today +0.09 / 0.48%
Volume 1.7K
523620 On Other Exchanges
Symbol
Exchange
523620 is not on other exchanges.
As of 6:40 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

pharmasia ltd (523620) Snapshot

Open
$18.83
Previous Close
$18.91
Day High
$19.05
Day Low
$18.83
52 Week High
05/20/13 - $21.50
52 Week Low
07/30/12 - $9.95
Market Cap
30.5M
Average Volume 10 Days
2.0K
EPS TTM
$4.73
Shares Outstanding
1.6M
EX-Date
--
P/E TM
4.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMASIA LTD (523620)

Related News

No related news articles were found.

pharmasia ltd (523620) Related Businessweek News

No Related Businessweek News Found

pharmasia ltd (523620) Details

Phaarmasia Limited manufactures and sells pharmaceutical products and drugs in India and Nepal. The company offers pharmaceutical formulations, cosmetics, and creams. It also provides skin/face creams, tooth paste, and oral contraceptive pills. The company is based in Hyderabad, India.

pharmasia ltd (523620) Top Compensated Officers

Managing Director and Director
Total Annual Compensation: --
Executive Director, Member of Audit Committee...
Total Annual Compensation: 480.0K
Compensation as of Fiscal Year 2012.

pharmasia ltd (523620) Key Developments

Phaarmasia Limited, Board Meeting, May 29, 2013

Phaarmasia Limited, Board Meeting, May 29, 2013. Agenda: To consider audited results.

Phaarmasia Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2012

Phaarmasia Limited announced unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales/income from operations of INR 17.529 million against INR 40.085 million a year ago. Profit from operations before other income, interest and exceptional items was INR 2.523 million against INR 2.101 million a year ago. Profit from ordinary activities before tax was INR 2.531 million against INR 2.101 million a year ago. Net profit for the period was INR 2.063 million against INR 1.776 million or INR 0.26 per basic and diluted share a year ago. Total income from operations was INR 17.529 million against INR 40.085 million a year ago. For the nine months, the company reported net sales/income from operations of INR 44.295 million against INR 317.213 million a year ago. Profit from operations before other income, interest and exceptional items was INR 1.264 million against INR 6.915 million a year ago. Profit from ordinary activities before tax was INR 1.253 million against INR 6.928 million a year ago. Net profit for the period was INR 1.022 million or INR 0.15 per basic and diluted share against INR 6.268 million or INR 0.92 per basic and diluted share a year ago. Total income from operations was INR 44.349 million against INR 317.213 million a year ago.

Phaarmasia Limited, Board Meeting, Feb 12, 2013

Phaarmasia Limited, Board Meeting, Feb 12, 2013. Agenda: To consider quarterly results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:IN 15.15 INR 0.00

523620 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 523620.
View Industry Companies
 

Industry Analysis

523620

Industry Average

Valuation 523620 Industry Range
Price/Earnings 54.4x
Price/Sales 1.4x
Price/Book 1.3x
Price/Cash Flow 15.9x
TEV/Sales 1.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMASIA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.